Spain· ES:59169
MANERIX 150 COMPRIMIDOS RECUBIERTOS CON PELICULA.
A medicinal product containing moclobemida, registered in Spain by Viatris Healthcare Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- moclobemida
- Manufacturer
- Viatris Healthcare Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo88046830EUR 5.18
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moclobemida in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomManerix 150mg tabletsNecessity Supplies Ltd
- FinlandAurorixParanova Oy
- NorwayAurorixViatris AS
- GermanyAurorixViatris Healthcare Gmbh
- CanadaMANERIXBAUSCH HEALTH, CANADA INC.
- CzechiaAURORIXVIATRIS HEALTHCARE LIMITED, Dublin
- SwedenAurorix 150 mg Filmdragerad tablettEbb Medical AB
- SwitzerlandAurorix 150
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Aurorix
- Belgium · Moclobemide Sandoz
- Czechia · Aurorix
- Germany · Aurorix, Moclobemid 1 A Pharma
- Finland · Aurorix
- France · Moclamine
- United Kingdom (Northern Ireland) · Manerix, Moclobemide
- Hungary · Aurorix
- Ireland · Manerix
- Netherlands · Moclobemide Sandoz
- Norway · Aurorix
- Poland · Aurorix, Mobemid
- Portugal · Aurorix, Zorix
- Sweden · Aurorix
- Slovenia · Aurorix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6b3b0c5-ea01-4da6-87b7-42815958321d GET /v1/drugs/d6b3b0c5-ea01-4da6-87b7-42815958321d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":696898800000}",
"nregistro": "59169",
"substance": "moclobemida"
}See everything about moclobemida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.